Pamela Martin's Blog - Posts Tagged "deep-state"
Big Pharma and Their Agreement with the US Government To Keep You Sick
It’s no secret that there’s an opium epidemic plaguing North America, and it’s been a growing issue for decades. Many people often picture drug dealers as these scary individuals selling pills on streets, when in reality, the drug pushers responsible for the abuse of opioids, opium, and heroin are largely the U.S. government and doctors.
That’s right: The U.S. government and physicians are deeply connected to the opium trade. You have physicians heavily pushing and marketing opioids, and then you have the U.S. government governing the opium trade.
A recently published study in the American Journal of Public Health actually proved just how deep this problem runs in regards to the doctor-opioid relationship, proving that opioids represent a lucrative business for both physicians and Big Pharma.
We fight wars in Afghanistan for control of their opium fields. The US controls the opium market so wouldn't it make sense to fully capitalize on profits by pushing opioid products into the population? Opioids are being prescribed to animal patients, child patients, adult and elderly patients for no other reason than to push profits back to an already lucrative $350 Billion dollar industry.
That’s right: The U.S. government and physicians are deeply connected to the opium trade. You have physicians heavily pushing and marketing opioids, and then you have the U.S. government governing the opium trade.
A recently published study in the American Journal of Public Health actually proved just how deep this problem runs in regards to the doctor-opioid relationship, proving that opioids represent a lucrative business for both physicians and Big Pharma.
We fight wars in Afghanistan for control of their opium fields. The US controls the opium market so wouldn't it make sense to fully capitalize on profits by pushing opioid products into the population? Opioids are being prescribed to animal patients, child patients, adult and elderly patients for no other reason than to push profits back to an already lucrative $350 Billion dollar industry.
